Mr.
Speaker, I have indicated to both types of pharmaceutical industries, the generic and the multinationals, that it is important for them to consider the impact of these regulations. Despite their highly complicated nature, it is vital that they work to the benefit of all Canadians.
I would, therefore, ask the hon. member to explain his position on these regulations. I am open to his ideas, because it is important for us to determine the best way of implementing the regulations.